ClinicalTrials.Veeva

Menu

Healthcare Integrity & Anti-Fraud Enforcement (PHX-AFK-US)

T

Truway Health, Inc.

Status

Invitation-only

Conditions

Validator Oversight & DAO Governance
Supply Chain Vulnerabilities
Regulatory Escalation Pathways
Governance Failures
Kickback Networks
Whistleblower Activation
Public Transparency & Auditability
Healthcare Fraud Schemes

Treatments

Other: Validator-Governed Reform & Regulatory Escalation Protocol
Device: Coalition-Grade Validator Dashboard Module (CVDM-1)
Drug: Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1)

Study type

Observational

Funder types

Industry

Identifiers

NCT07217730
PRS-HI-AFK-SC-US-101325-GS

Details and patient eligibility

About

The PHX-AFK-US Protocol is a coalition-backed regulatory scaffold designed to restore healthcare integrity across U.S. facilities. It targets fraud, kickback schemes, and supply chain opacity through validator governance, smart contract enforcement, and public transparency. Anchored by notarized affidavits, NFT fiscal instruments, and dashboard oversight, this protocol empowers whistleblowers, mobilizes validators, and escalates complaints to federal and state regulators. It integrates secure audit trails, DAO voting logic, and asset freeze triggers to ensure accountability, reform, and systemic trust.

Full description

The PHX-AFK-US Protocol is a coalition-backed regulatory scaffold designed to restore healthcare integrity across U.S. facilities. It targets fraud, kickback schemes, and supply chain opacity through validator governance, smart contract enforcement, and public transparency. Anchored by notarized affidavits, NFT fiscal instruments, and dashboard oversight, this protocol empowers whistleblowers, mobilizes validators, and escalates complaints to federal and state regulators. It integrates secure audit trails, DAO voting logic, and asset freeze triggers to ensure accountability, reform, and systemic trust.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Facility has documented billing, compliance, or procurement irregularities.

Facility participates in coalition validator onboarding and SHA-256 protocol enrollment.

Facility provides access to billing, procurement, and whistleblower-anchored datasets for auditing.

Exclusion criteria

Facility refuses validator onboarding or coalition integration.

Facility lacks traceable procurement or compliance records.

Facility has no whistleblower declaration or validation artifact.

Facility operates outside U.S. jurisdiction or coalition-recognized governance zones.

Trial design

100 participants in 1 patient group

Flagged Healthcare Facilities - Validator Oversight Cohort
Description:
This cohort consists of U.S. healthcare facilities identified through validator affidavits, whistleblower declarations, and coalition intelligence as exhibiting patterns of fraud, kickback schemes, or supply chain vulnerabilities. Facilities are enrolled into the PHX-AFK-US Protocol for prospective observation, reform enforcement, and regulatory escalation. Each facility is subject to smart contract triggers, DAO voting logic, and public dashboard transparency. No biospecimens are retained; all data is notarized via SHA-256 hash anchors and integrated into NFT fiscal declarations and validator ballot modules.
Treatment:
Drug: Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1)
Device: Coalition-Grade Validator Dashboard Module (CVDM-1)
Other: Validator-Governed Reform & Regulatory Escalation Protocol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems